Académique Documents
Professionnel Documents
Culture Documents
Kara K. Seaton, MD
Emergency Department
Fellow, Pediatric Emergency Medicine, Childrens Hospital and
Clinics of Minnesota, Minneapolis, MN
Anupam Kharbanda, MD
Director of Research, Emergency and Trauma Services,
Abstract Childrens Hospital and Clinics of Minnesota, Minneapolis, MN
Peer Reviewers
Kawasaki disease, also known as mucocutaneous lymph node syn- Catherine Sellinger, MD, FAAP
Associate Director, Pediatric Emergency Services, Childrens
drome, was first described in Japan in 1967. It is currently the leading Hospital at Montefiore; Assistant Professor of Pediatrics, Albert
cause of acquired heart disease in children in the United States. Un- Einstein College of Medicine, Bronx, NY
treated Kawasaki disease may lead to the formation of coronary artery Michael J. Stoner, MD
Assistant Professor of Pediatrics, The Ohio State University
aneurysms and sudden cardiac death in children. This vasculitis pres- College of Medicine; Attending Physician, Pediatric Emergency
ents with fever for 5 days, plus a combination of key criteria. Because Medicine, Nationwide Childrens Hospital, Columbus, OH
each of the symptoms commonly occurs in other childhood illnesses, CME Objectives
the disease can be difficult to diagnose, especially in children who Upon completion of this article, you should be able to:
present with an incomplete form of the disease. At this time, the etiol- 1. Describe the clinical features and risks associated with
ogy of the disease remains unknown, and there is no single diagnostic Kawasaki disease.
2. Identify epidemiologic trends in Kawasaki disease in high-
test to confirm the diagnosis. This issue reviews the presentation, diag- risk populations.
nostic criteria, and management of Kawasaki disease in the emergency 3. Assess the differences between complete and incomplete
presentations of Kawasaki disease.
department. Emergency clinicians should consider Kawasaki disease 4. Discuss the initial treatment of Kawasaki disease and
as a diagnosis in pediatric patients presenting with prolonged fever, as possible options for treating resistant disease.
prompt evaluation and management can significantly decrease the risk Prior to beginning this activity, see Physician CME
of serious cardiac sequelae. Information on the back page.
Editor-in-Chief Ilene Claudius, MD Therapeutics; Research Director, Melissa Langhan, MD, MHS Christopher Strother, MD
Associate Professor of Emergency Pediatric Emergency Medicine, BC Associate Professor of Pediatrics, Assistant Professor, Director,
Adam E. Vella, MD, FAAP Medicine, Keck School of Medicine Children's Hospital, Vancouver, BC, Fellowship Director, Pediatric Undergraduate and Emergency
Associate Professor of Emergency of the University of Southern Canada Emergency Medicine, Director of Simulation, Icahn School of
Medicine, Pediatrics, and Medical California, Los Angeles, CA Education, Pediatric Emergency Medicine at Mount Sinai, New
Education, Director Of Pediatric Alson S. Inaba, MD, FAAP
Medicine, Yale School of Medicine, York, NY
Emergency Medicine, Icahn Ari Cohen, MD Associate Professor of Pediatrics,
New Haven, CT
School of Medicine at Mount Sinai, Chief of Pediatric Emergency University of Hawaii at Mnoa AAP Sponsor
New York, NY Medicine Services, Massachusetts John A. Burns School of Medicine, Robert Luten, MD
General Hospital; Instructor in Division Head of Pediatric Professor, Pediatrics and Martin I. Herman, MD, FAAP, FACEP
Associate Editor-in-Chief Pediatrics, Harvard Medical Emergency Medicine, Kapiolani Emergency Medicine, University of Professor of Pediatrics, Attending
School, Boston, MA Medical Center for Women and Florida, Jacksonville, FL Physician, Emergency Medicine
Vincent J. Wang, MD, MHA Department, Sacred Heart
Associate Professor of Pediatrics, Marianne Gausche-Hill, MD, Children, Honolulu, HI Garth Meckler, MD, MSHS Childrens Hospital, Pensacola, FL
Keck School of Medicine of the FACEP, FAAP Madeline Matar Joseph, MD, FAAP, Associate Professor of Pediatrics,
University of Southern California; Professor of Clinical Medicine, FACEP University of British Columbia; International Editor
Associate Division Head, David Geffen School of Medicine Professor of Emergency Medicine Division Head, Pediatric Lara Zibners, MD, FAAP
Division of Emergency Medicine, at the University of California at and Pediatrics, Chief and Medical Emergency Medicine, BC Honorary Consultant, Paediatric
Children's Hospital Los Angeles, Los Angeles; Vice Chair and Chief, Director, Pediatric Emergency Children's Hospital, Vancouver, Emergency Medicine, St Mary's
Los Angeles, CA Division of Pediatric Emergency Medicine Division, University BC, Canada Hospital, Imperial College Trust;
Medicine, Harbor-UCLA Medical of Florida Medical School-
Editorial Board Center, Los Angeles, CA Jacksonville, Jacksonville, FL
Joshua Nagler, MD EM representative, Steering Group
Assistant Professor of Pediatrics, ATLS-UK, Royal College of
Jeffrey R. Avner, MD, FAAP Michael J. Gerardi, MD, FAAP, Stephanie Kennebeck, MD Harvard Medical School; Surgeons, London, England
Professor of Clinical Pediatrics FACEP, President-Elect Associate Professor, University Fellowship Director, Division of
and Chief of Pediatric Emergency Associate Professor of Emergency of Cincinnati Department of Emergency Medicine, Boston Pharmacology Editor
Medicine, Albert Einstein College Medicine, Icahn School of Pediatrics, Cincinnati, OH Childrens Hospital, Boston, MA James Damilini, PharmD, MS,
of Medicine, Childrens Hospital at Medicine at Mount Sinai; Director, Anupam Kharbanda, MD, MS James Naprawa, MD BCPS
Montefiore, Bronx, NY Pediatric Emergency Medicine, Research Director, Associate Associate Clinical Professor Clinical Pharmacy Specialist,
Steven Bin, MD Goryeb Children's Hospital, Emergency Medicine, St.
Fellowship Director, Department of Pediatrics, The Ohio State
Associate Clinical Professor, Morristown Medical Center, Joseph's Hospital and Medical
of Pediatric Emergency Medicine, University College of Medicine;
Division of Pediatric Emergency Morristown, NJ Center, Phoenix, AZ
Children's Hospitals and Clinics of Attending Physician, Emergency
Medicine, UCSF Benioff Childrens Sandip Godambe, MD, PhD Minnesota, Minneapolis, MN Department, Nationwide Childrens Quality Editor
Hospital, University of California, Vice President, Quality & Patient Hospital, Columbus, OH
San Francisco, CA Tommy Y. Kim, MD, FAAP, FACEP
Safety, Professor of Pediatrics and Assistant Professor of Emergency Steven Choi, MD
Steven Rogers, MD
Richard M. Cantor, MD, FAAP, Emergency Medicine, Attending Medical Director of Quality,
Medicine and Pediatrics, Loma Assistant Professor, University of
FACEP Physician, Children's Hospital Director of Pediatric Cardiac
Linda University Medical Center and Connecticut School of Medicine,
Professor of Emergency Medicine of the King's Daughters Health Inpatient Services, The Childrens
Childrens Hospital, Loma Linda, CA; Attending Emergency Medicine
and Pediatrics, Director, Pediatric System, Norfolk, VA Hospital at Montefiore; Assistant
California Emergency Physicians, Physician, Connecticut Children's
Emergency Department, Medical Professor of Pediatrics, Albert
Ran D. Goldman, MD Riverside, CA Medical Center, Hartford, CT
Director, Central New York Einstein College of Medicine,
Professor, Department of Pediatrics,
Poison Control Center, Golisano Bronx, NY
University of British Columbia;
Children's Hospital, Syracuse, NY Co-Lead, Division of Translational
Case Presentation Since it was first described, Kawasaki disease has
been well characterized. Affected children generally
A 3-year-old girl presents to the emergency department have fever for at least 5 days, plus 4 of 5 key criteria.
for evaluation of fever. Her mother reports that the child These criteria include conjunctival injection, oral
has had a fever for the past 5 days, with temperatures mucosal changes, polymorphous rash, distal extremity
ranging from 38.3C (101F) to 40C (104F). The child changes, and cervical lymphadenopathy.5,6 Nonspe-
has some rhinorrhea, but no significant cough. She has cific symptoms, such as vomiting, joint pain, cough,
been complaining of abdominal pain and had 2 episodes of decreased oral intake, rhinorrhea, and abdominal pain,
nonbilious vomiting in the last 2 days. She was evalu- may also be present, and may make the diagnosis
ated at her pediatricians office 2 days ago, and she was more challenging. To add to the diagnostic challenge,
diagnosed with a viral illness. Her mother reports the some patients may develop an incomplete form of the
subsequent development of a red rash that started on disease. These children will not meet all of the clinical
the childs face and chest, and it is now present on her criteria of Kawasaki disease, but they may still develop
trunk, back, and extremities. Her lips are cracked, and her the cardiovascular complications. Incomplete Kawasaki
mother attributes this to poor oral intake over the past few disease accounts for 15% to 20% of Kawasaki disease
days. Today, the child was noted to have red eyes, without diagnoses, and it is more common in children aged < 6
discharge, and redness in the genital area. The mother has months and in children aged > 5 years.5
not noticed swelling of the extremities or peeling skin. The No single laboratory test can be used to establish
remainder of the review of systems is negative. The child the diagnosis of Kawasaki disease, although labora-
was previously healthy, with no prior hospitalizations, tory testing can be used to distinguish this disease
and she is fully immunized. She attends a small, in-home from other disease entities. Thus, the diagnosis must
daycare, but none of the other children there have been be made using a combination of a thorough history,
sick. On physical examination, the child appears tired physical examination, and laboratory results. If some
and ill, although she is not in distress. Her temperature of the diagnostic criteria are met and Kawasaki dis-
at triage is 39.8C (103.6F). She is tachycardic, with ease is suspected, the current recommendations are to
a heart rate of 166 beats/min; and tachypneic, with a obtain an echocardiogram to assess coronary artery
respiratory rate of 48 breaths/min. Her eyes are injected involvement. Ideally, this should be done within 10
bilaterally, without purulent discharge. Her tympanic days of the onset of fever to minimize the risk of car-
membranes are normal. She has dry, fissured lips. She has diovascular complications.
shotty cervical lymphadenopathy. Her lungs are clear to Kawasaki disease is rarely fatal, but virtually
auscultation, and the cardiovascular examination reveals all deaths result from cardiac sequelae. In fact, this
tachycardia without murmurs. Her abdomen is soft and disease has now surpassed rheumatic heart disease
mildly tender to palpation throughout, with no hepato- as the leading acquired heart disease in children in
splenomegaly. Her extremities are warm, well perfused, the United States.5 Coronary artery aneurysms occur
and without swelling. Her skin is notable for a fine, ery- in 15% to 25% of untreated children. Coronary artery
thematous, maculopapular rash on the face, chest, back, aneurysm has been known to lead to myocardial
and extremities. The patients ill appearance and history infarction, ischemic heart disease, and sudden car-
of prolonged fever are concerning for the possibility of diac death. Peak mortality occurs 15 to 45 days after
Kawasaki disease, but you arent sure that she meets all of the development of fever. However, sudden cardiac
the criteria. You wonder if there are infections you should death has been documented years after the diagnosis
worry about. Are there laboratory tests you could order of Kawasaki disease. In-hospital mortality is cur-
that would help you differentiate Kawasaki disease from rently estimated to be 0.17% in the United States.7
infection? What about diagnostic imaging tests? Should
you start any medications? Are there any other complica- Critical Appraisal Of The Literature
tions that you should be concerned about?
A literature search was performed using both
Introduction PubMed and Ovid. The initial search on PubMed us-
ing the term Kawasaki disease resulted in 8170 articles.
Kawasaki disease was initially described in Japan in This was then decreased to 3458 articles by limiting
1967 by Tomisaku Kawasaki.1-4 Originally known as the results to children (aged birth to 18 years) and
mucocutaneous lymph node syndrome, it is an acute, articles published in English. A similar search in
self-limited, febrile vasculitis of infancy and child- Ovid using the same terms produced 4593 articles.
hood. Kawasaki disease primarily affects small- and Guidelines from the American Academy of Pediat-
medium-sized arteries, including the coronary arter- rics (AAP) in partnership with the American Heart
ies. Although it is a self-limited disease, early diagno- Association (AHA) were reviewed. Search of the
sis and treatment is critical to preventing the forma- Cochrane Database of Systematic Reviews produced
tion of coronary artery aneurysms, which may lead to reviews of Kawasaki disease treatment using intra-
acquired cardiovascular disease and sudden death. venous immunoglobulin (IVIG) and aspirin. The ref-
This figure was published in Zitelli and Davis' Atlas of Pediatric Physi- This figure was published in Zitelli and Davis' Atlas of Pediatric Physi-
cal Diagnosis, 6th edition, Torok K, Rosen P, Kawasaki Disease, cal Diagnosis, 6th edition, Torok K, Rosen P, Kawasaki Disease,
pages 289-291, Copyright Elsevier 2012. Used with permission. pages 289-291, Copyright Elsevier 2012. Used with permission.
*Complete Kawasaki disease is defined as fever for 5 days plus 4 of the 5 diagnostic criteria.
Reprinted from the Journal of the American Academy of Dermatology, Volume 69, Issue 4, Stephanie Byers, MD, Stanford T. Shulman, MD, and Amy
S. Paller, MD, Kawasaki disease, Part I. Diagnosis, clinical features, and pathogenesis, pages 501.e1-501.e11. Copyright 2013, with permission from
Elsevier.
This figure was published in Zitelli and Davis' Atlas of Pediatric Physi-
cal Diagnosis, 6th edition, Torok K, Rosen P, Kawasaki Disease,
pages 289-291, Copyright Elsevier 2012. Used with permission.
This figure was published in Zitelli and Davis' Atlas of Pediatric Physi-
cal Diagnosis, 6th edition, Torok K, Rosen P, Kawasaki Disease,
pages 289-291, Copyright Elsevier 2012. Used with permission.
To view a full-color version of this issue's photos, scan
the QR code with a smartphone or tablet or go to:
www.ebmedicine.net/KawasakiDiseaseSigns.
This figure was published in Zitelli and Davis' Atlas of Pediatric Physi-
cal Diagnosis, 6th edition, Torok K, Rosen P, Kawasaki Disease,
pages 289-291, Copyright Elsevier 2012. Used with permission.
NO YES
NO YES
Abbreviations: ALT, alanine aminotransferase; ASA, acetyl salicylic acid (aspirin); CBC, complete blood count; CRP, C-reactive protein; ED, emergency department;
ESR, erythrocyte sedimentation rate; IVIG, intravenous immunoglobulin.
This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patients individual needs. Failure
to comply with this pathway does not represent a breach of the standard of care.
Copyright 2015 EB Medicine. 1-800-249-5770. No part of this publication may be reproduced in any format without written consent of EB Medicine.
1. I thought the child had a viral illness, so I treat- 4. I was unsure of the diagnosis, so I waited to
ed her with antipyretics and discharged her. start treatment with IVIG.
Fevers are common in children, and many Delays in making the diagnosis and delays in
children with fever will likely have a viral starting treatment significantly increase the
illness. Many of the other symptoms of risk of developing coronary artery aneurysms.
Kawasaki disease are found in viral illnesses, If the emergency clinician has a high suspicion
such as rash and conjunctivitis. However, for Kawasaki disease and laboratory values
Kawasaki disease should be considered in all support the diagnosis, treatment should be
patients with parental report of prolonged initiated promptly. Echocardiogram should be
fever. Failure to recognize and treat Kawasaki performed as soon as possible, but this should
disease in a timely manner can have catastrophic not delay treatment.
consequences.
5. I know that the guidelines recommend echo-
2. The child did not meet the criteria for all of cardiography for assessment of coronary arter-
the symptoms on presentation to the ED, so I ies when the suspicion is high for Kawasaki
thought she could not have Kawasaki disease. disease, so I delayed treatment to obtain the
The diagnosis of incomplete Kawasaki disease imaging.
can be difficult. It is necessary to have a high Ideally, initial echocardiography should be
index of suspicion with regard to Kawasaki performed on the day of diagnosis. Guidelines
disease in children with a fever lasting 5 days. from the AHA and the AAP recommend
It is important to note that symptoms may prompt echocardiography once Kawasaki
present sequentially rather than simultaneously, disease is diagnosed or suspected, although
and, thus, some of the diagnostic symptoms delays in obtaining imaging should not delay
may be resolved prior to presentation to the ED. initiation of treatment.
If a patient has fever plus 2 to 3 of the diagnostic
criteria, further evaluation with laboratory 6. The patient failed to respond to initial stan-
studies and possibly an echocardiogram is dard treatment of IVIG and aspirin, and I
warranted to evaluate for Kawasaki disease. By didnt know what to choose next.
most estimates, approximately 20% of patients Although the standard therapy of IVIG plus
with Kawasaki disease will fall into the category high-dose aspirin is effective for most patients
of incomplete disease. with Kawasaki disease, it is estimated that
approximately 10% to 20% of patients will fail
3. I suspected Kawasaki disease, but I was to respond to this therapy. Second-line therapy
unsure of the diagnosis, so I waited for the usually consists of retreatment with IVIG,
laboratory tests to return before beginning potentially in combination with corticosteroids.
any treatment. Although further research is needed, infliximab
There is no single diagnostic test to confirm is generally safe and should be considered as an
the diagnosis of Kawasaki disease. Diagnosis alternative therapy in treatment-resistant disease.
centers on the presence of the criteria for
Kawasaki disease, which include fever for at 7. I ordered an echocardiogram for the patient,
least 5 days, plus 4 of 5 of the following key but there were no findings, so I ruled out Ka-
criteria: conjunctival injection, oral mucosal wasaki disease.
changes, polymorphous rash, distal extremity It should be noted that a normal initial
changes, and cervical lymphadenopathy. echocardiogram should not be used to exclude
Treatment should not be delayed if the diagnosis the diagnosis of Kawasaki disease, especially if
can be confirmed by the history and physical physical examination findings and laboratory
examination. Early identification and treatment tests are consistent with the diagnosis.
of Kawasaki disease has been shown to reduce
the development of coronary artery aneurysms.
2 E A S Y 1. Go online to:
www.ebmedicine.net/NHLAG
WAYS TO 2. Call 1-800-249-5770 or
ORDER 678-366-7933
3 Ways to Order
1) Call 1-800-249-5770 2) Go online to www.ebmedicine.net/RHPAC 3) Detach lower portion and mail to:
5550 Triangle Pkwy, Ste 150 / Norcross, GA 30092
n Yes! Renew my Pediatric Emergency Medicine Practice subscription with this exclusive subscriber discount. I also
receive a copy of the Pediatric Emergency Medicine Practice Audio Series Vol. II when I renew via this special offer.
Please check one: n One-year subscription (12 issues) only $199 (a $100 savings)
n Two-year subscription (24 issues) only $378 (a $220 savings)
Name:_____________________________________________________________________
Address:___________________________________________________________________ Promotion Code:
City:__________________________ State:_______ ZIP:____________________________ RHPAC
Phone #:__________________ Email:___________________________________________
Signature: _________________________________________________________________
EB Medicine * 5550 Triangle Parkway, Suite 150 / Norcross, GA 30092 * 1-800-249-5770 * www.ebmedicine.net/RHPAC
AAP Accreditation: This continuing medical education activity has been reviewed by the
American Academy of Pediatrics and is acceptable for a maximum of 48 AAP credits per
year. These credits can be applied toward the AAP CME/CPD Award available to Fellows
and Candidate Fellows of the American Academy of Pediatrics.
Pediatric Emergency Needs Assessment: The need for this educational activity was determined by a survey
of medical staff, including the editorial board of this publication; review of morbidity and
Medicine Practice mortality data from the CDC, AHA, NCHS, and ACEP; and evaluation of prior activities
for emergency physicians.
Has Gone Mobile! Target Audience: This enduring material is designed for emergency medicine physicians,
physician assistants, nurse practitioners, and residents.
Goals: Upon completion of this activity, you should be able to: (1) demonstrate medical
decision-making based on the strongest clinical evidence; (2) cost-effectively diagnose
You can now view all Pediatric Emergency and treat the most critical ED presentations; and (3) describe the most common
medicolegal pitfalls for each topic covered.
Medicine Practice content on your iPhone
Discussion of Investigational Information: As part of the newsletter, faculty may be
or Android smartphone. Simply visit presenting investigational information about pharmaceutical products that is outside
www.ebmedicine.net from your mobile Food and Drug Administration approved labeling. Information presented as part of this
activity is intended solely as continuing medical education and is not intended to promote
device, and youll automatically be off-label use of any pharmaceutical product.
directed to our mobile site. Faculty Disclosure: It is the policy of EB Medicine to ensure objectivity, balance,
independence, transparency, and scientific rigor in all CME-sponsored educational
activities. All faculty participating in the planning or implementation of a sponsored
activity are expected to disclose to the audience any relevant financial relationships
On our mobile site, you can: and to assist in resolving any conflict of interest that may arise from the relationship.
Presenters must also make a meaningful disclosure to the audience of their discussions
View all issues of Pediatric Emergency Medicine of unlabeled or unapproved drugs or devices. In compliance with all ACCME
Practice since inception Essentials, Standards, and Guidelines, all faculty for this CME activity were
asked to complete a full disclosure statement. The information received is as
Take CME tests for all Pediatric Emergency follows: Dr. Seaton, Dr. Kharbanda, Dr. Sellinger, Dr. Stoner, Dr. Vella, Dr. Wang, Dr.
Damilini, and their related parties report no significant financial interest or other
Medicine Practice issues published within the last relationship with the manufacturer(s) of any commercial product(s) discussed in
3 years thats over 100 AMA Category 1 CreditsTM! this educational presentation.
Commercial Support: This issue of Pediatric Emergency Medicine Practice did not receive
View your CME records, including scores, dates of any commercial support.
completion, and certificates
Earning Credit: Two Convenient Methods: (1) Go online to www.ebmedicine.net/CME
And more! and click on the title of this article. (2) Mail or fax the CME Answer And Evaluation Form
with your June and December issues to EB Medicine.
Check out our mobile site, and give us your Hardware/Software Requirements: You will need a Macintosh or PC with internet
capabilities to access the website.
feedback! Simply click the link at the bottom of the
Additional Policies: For additional policies, including our statement of conflict of interest,
mobile site to complete a short survey to tell us source of funding, statement of informed consent, and statement of human and animal
what features youd like us to add or change. rights, visit http://www.ebmedicine.net/policies.
CEO & Publisher: Stephanie Williford Director of Editorial: Dorothy Whisenhunt Content Editors: Erica Carver, Jenique Meekins Editorial Assistant: Lesley Wood
Office Manager: Kiana Collier Member Services Representative: Paige Banks Director of Business Development: Susan Woodard Account Manager: Cory Shrider
Director of Marketing: Robin Williford Marketing Coordinator: Katherine Johnson
2. Mail or fax the Answer & Evaluation Form on the next page to
EB Medicine at the address or fax below.
5550 Triangle Parkway, STE 150 Norcross, GA 30092 1-800-249-5770 Outside U.S.: 1-678-366-7933
Fax: 1-770-500-1316 Email: ebm@ebmedicine.net Website: www.ebmedicine.net
Pediatric Emergency Medicine Practice CME Answer & Evaluation Form
Name: __________________________________________________________________________________
Address: _________________________________________________________________________________
_______________________________________________________________________________________
Phone number: ____________________________________________________________________________
E-mail address (required): ___________________________________________________________________
Please write your email address clearly. Certificates will be sent by email.
Check here if you need your certificate mailed:
Please fill in the appropriate box for 1. [a] [b] [c] [d] [e] 9. [a] [b] [c] [d] [e]
the correct answer for each question. 2. [a] [b] [c] [d] [e] 10. [a] [b] [c] [d] [e]
The test questions appear at the end of the 3. [a] [b] [c] [d] [e] 11. [a] [b] [c] [d] [e]
issue. Each question has only one correct
answer. If there are fewer questions on your
4. [a] [b] [c] [d] [e] 12. [a] [b] [c] [d] [e]
issue than listed here, leave the additional 5. [a] [b] [c] [d] [e] 13. [a] [b] [c] [d] [e]
questions blank. Please make a copy of the 6. [a] [b] [c] [d] [e] 14. [a] [b] [c] [d] [e]
completed answer form for your files 7. [a] [b] [c] [d] [e] 15. [a] [b] [c] [d] [e]
and return it to EB Medicine at the address 8. [a] [b] [c] [d] [e] 16. [a] [b] [c] [d] [e]
or fax number below.
Please take a few moments to complete this Evaluation Form. Your opinions will ensure continuing program relevance and quality.
Enter the extent to which you agree with the following statements.
Response codes: 5=strongly agree; 4=agree; 3=neutral; 2=disagree; 1=strongly disagree
1. ____ The overall activity content was pertinent to my needs and expectations.
2. ____ The information was presented in an impartial and unbiased manner.
3. ____ I learned information that will enhance my professional effectiveness.
4. ____ Adequate faculty disclosure was given.
5. ____ The test questions were clear and appropriate.
6. ____ The information presented in this CME quiz was objective, balanced, and of scientific rigor.
7. ____ The authors were NOT biased in their discussion of any commercial product or service.
8. ____ The content in this activity is useful in my everyday practice.
9. ____ The first CME objective (listed on the cover of the article) was met for this activity.
10. ____ The second CME objective (listed on the cover of the article) was met for this activity.
11.What clinical information did you learn that was of value to you? ___________________________________________________
12. How did the clinical information you learned impact positively or change the way you care for your patients? _________________
13. For future activities, what personal professional gap would you like us to fill? _________________________________________
14. What do you like MOST about Pediatric Emergency Medicine Practice? ____________________________________________
15. What do you like LEAST about Pediatric Emergency Medicine Practice? ____________________________________________
16. Please provide any additional comments. _____________________________________________________________________
5550 Triangle Pkwy, Ste 150 Norcross, GA 30092 1-800-249-5770 Fax: 770-500-1316 ebm@ebmedicine.net www.ebmedicine.net
ANNOUNCING: Subscription Discount Offer
Pediatric Emergency Medicine Practice
5550 Triangle Pkwy, Ste 150 Norcross, GA 30092
1-800-249-5770 or 1-678-366-7933 / Fax: 1-770-500-1315 Yes! Start my Pediatric Emergency Medicine Practice subscription with
ebm@ebmedicine.netwww.ebmedicine.net this exclusive discount. Promotion Code SAMPP. Please check one:
o One-year subscription (12 issues)only $199 (a $100 savings) OR
o Two-year subscription (24 issues)only $378 (a $220 savings)
Payment options:
Shipping information: Bill my: o Visa o Mastercard o American Express
Name: ___________________________________________________________ Card # __________________________________________ Exp. ______
Address: _________________________________________________________
Signature (required): _________________________________________
________________________________________________________________ OR o Check enclosed (made payable to EB Medicine)
City, State, ZIP: __________________________________________________ Phone: ___________________________________________________
Email: ____________________________________________________
Phone number: ___________________________________________________
We respect your privacy, and we hate spam as much as you do! We will
E-mail address: ___________________________________________________ never share your email address and you can easily opt out at any time.
We respect your privacy, and we hate spam as much as you do! We will I also receive An Evidence-Based Approach to
never share your email address, and you can easily opt out at any time. Pediatric Emergenciesa $149 bookfree.
DESCRIPTION AMOUNT
Pediatric Emergency Medicine Practice: 12 monthly evidence-based print issues per year $199 $100
off!
48 AMA PRA Category 1 CreditsTM, 48 ACEP Category 1 credits, and 48 AAP Prescribed FREE
CME credits per year
Full online access to searchable archives, CME testing, and an additional 144 AMA PRA FREE
Category 1 CreditsTM per year or 144 ACEP Category 1, AAP Prescribed CME credits
Our Guarantee: If you do not receive practice-improving information in each and every
Pediatric Emergency Medicine Practice issue, simply call us to receive a full, cheerful, and INCLUDED
immediate refund. No questions asked.
This is not a bill. You are under no obligation to pay. This is an offer to subscribe at an exclusive discounted rate.